Matrik Biotek Shikari® (Q-BEVA) ELISA has been especially developed for the quantitative analysis of free Bevacizumab (Avastin®) in serum and plasma samples.
|Required Volume (µl)||5|
|Total Time (min)||70|
|Detection Limit (ng/mL)||30|
|Spike Recovery (%)||Between 85-115|
|Shelf Life (year)||1|
Please note that the documentation provided is for reference use only. For the most updated version, please contact us.
For Research Use Only
Manufactured by Matriks Biotek Co.
* AVASTIN® IS A REGISTERED TRADEMARK OF GENENTECH, INC.
Questions about this product? Ready to place an order? Email us at email@example.com or give us a call: (650) 486-1541